Previously, we have demonstrated that it is possible to induce PR3-ANCA production using an in vitro system [11,12] based on stimulation of peripheral blood mononuclear cells (PBMCs) and postulated that this may be a more accurate reflection of the ongoing pathogenic process and active ANCA production in GPA patients. Here, PRTN3 is linked to granulomatosis with polyangiitis.